JCJúnia de Oliveira Costa

Júnia de Oliveira Costa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Júnia de Oliveira Costa has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Epidemiology of snakebites in the Catalão microregion, Goiás, Brazil

    by Douglas Gonçalves Mendonça, Carla Cristine Neves Mamede, Francisco Ricardo Miranda Pinto, Júnia De Oliveira Costa, Rodrigo Rodrigues Franco, Edigar Henrique Vaz Dias

    Snakebites represent a major public health problem, especially in tropical countries such as Brazil. This study analyzed the epidemiology of snakebites in the geographical microregion of Catalão, Goiás, from 2017 to 2023. This is a descriptive, quantitative, and retrospective analysis based on data collection from the Ministry of Health's Notifiable Diseases Information System (SINAN). A total of 273 cases of snakebites were reported, 62.27% of which were bothropic. There was a greater incidence of males (81.32%) and those aged between 40 and 59 years (39.93%). It is noteworthy that 75% of the accidents were non-occupational. Approximately half of the cases were classified as mild (50.43%). The anatomical region of the foot and leg was the most affected. Most victims received medical care within 3 hours (89.07%), underwent serum therapy (89.22%) and were cured. The municipality of Três Ranchos had the highest incidence of cases (513.52/100.000 inhabitants), while Catalão had the highest annual average (17.4) and the highest percentage of occurrence (35.8%). The epidemiological study of snakebite accidents contributes to understanding the impact of this disease on the population and provides data for the development of health surveillance, awareness and prevention measures in the region.

  • Open Access

    Bothrops Moojeni Snake Venom: A Source of Potential Therapeutic Agents Against Hemostatic Disorders

    by Natália Barreira Silva, Edigar Henrique Vaz Dias, Júnia de Oliveira Costa, Carla Cristine Neves Mamede

    Hemostasis is a complex set of biological processes responsible for blood fluidity within normal vessels and for the physiological interruption of bleeding in cases of vascular injury. Bothrops moojeni snake venom is rich in bioactive compounds of pharmacological and clinical interest since its protein components are capable of interfering with many points of the hemostatic process. Here, we present the B. moojeni venom proteins that affect hemostasis and discuss their pharmacological and clinical potential. This systematic review was conducted [...] Abstract Hemostasis is a complex set of biological processes responsible for blood fluidity within normal vessels and for the physiological interruption of bleeding in cases of vascular injury. Bothrops moojeni snake venom is rich in bioactive compounds of pharmacological and clinical interest since its protein components are capable of interfering with many points of the hemostatic process. Here, we present the B. moojeni venom proteins that affect hemostasis and discuss their pharmacological and clinical potential. This systematic review was conducted


  • Systemic alterations induced by phospholipase A2, BmooTX‐I, isolated from Bothrops moojeni snake venom

    by Kellen Cristina Torres Costa, Bruna Barbosa de Sousa, Edigar Henrique Vaz Dias, Déborah Fernanda da Cunha Pereira, Mariana Santos Matias, Wilson Júnior Oliveira, Antônio Vicente Mundim, Carla Cristine Neves Mamede, Luíz Fernando Moreira Izidoro, Júnia de Oliveira Costa, et al.

    Summary: Ophidic accidents are among the problems of public health in Brazil. The components from bothropic venom are responsible for many systemic clinical complications resulting from envenomation. The present work aimed to analyse the systemic changes induced in mice after intraperitoneal administration of BmooTX‐I, a myotoxic acidic phospholipase A2 isolated from Bothrops moojeni venom. Urinalysis was performed and the following plasma biochemical markers were documented: urea, creatinine and uric acid (renal function); glucose and amylase (pancreatic function); alanine aminotransferase, alkaline phosphatase and gamma‐GT (intra‐ and extrahepatic function); creatine kinase and enzymatic lactate (muscle function). Our results showed that after the intraperitoneal injection of BmooTX‐I the urine of these animals showed glycosuria, proteinuria, haematuria, bacteriuria, bilirubinuria, polyuria and nitrite. The plasma biochemical analysis showed alterations in levels of urea, creatinine and uric acid. Amylase concentration was not altered significantly, but the plasma glucose increased significantly compared to controls. The plasma levels of alanine aminotransferase and alkaline phosphatase decreased and increased, respectively, in these same animals. On the other hand, the plasma γGT concentration did not undergo significant modification compared to the control group. The plasma concentration of CK increased, while the enzymatic lactate concentration decreased after the injection of the BmooTX‐I. Therefore, in mice BmooTX‐I is capable of causing systemic alterations which manifest as renal, muscular, hepatic and pancreatic impairment.


  • Open Access

    A New Platelet-Aggregation-Inhibiting Factor Isolated fromBothrops moojeniSnake Venom

    by Bruna Barbosa de Sousa, Carla Cristine Neves Mamede, Mariana Santos Matias, Déborah Fernanda da Cunha Pereira, Mayara Ribeiro de Queiroz, Edigar Henrique Vaz Dias, Anielle Christine Almeida Silva, Noelio Oliveira Dantas, Júnia de Oliveira Costa, Fábio de Oliveira

    This work reports the purification and functional characterization of BmooPAi, a platelet-aggregation-inhibiting factor fromBothrops moojenisnake venom. The toxin was purified by a combination of three chromatographic steps (ion-exchange on DEAE-Sephacel, molecular exclusion on Sephadex G-75, and affinity chromatography on HiTrap™ Heparin HP). BmooPAi was found to be a single-chain protein with an apparent molecular mass of 32 kDa on 14% SDS-PAGE, under reducing conditions. Sequencing of BmooPAi by Edman degradation revealed the amino acid sequence LGPDIVPPNELLEVM. The toxin was devoid of proteolytic, haemorrhagic, defibrinating, or coagulant activities and induced no significant oedema or hyperalgesia. BmooPAi showed a rather specific inhibitory effect on ristocetin-induced platelet aggregation in human platelet-rich plasma, whereas it had little or no effect on platelet aggregation induced by collagen and adenosine diphosphate. The results presented in this work suggest that BmooPAi is a toxin comprised of disintegrin-like and cysteine-rich domains, originating from autolysis/proteolysis of PIII SVMPs fromB. moojenisnake venom. This toxin may be of medical interest because it is a platelet aggregation inhibitor, which could potentially be developed as a novel therapeutic agent to prevent and/or treat patients with thrombotic disorders.


  • Open Access

    BaltDC: purification, characterization and infrared spectroscopy of an antiplatelet DC protein isolated from Bothrops alternatus snake venom

    by Mariana Santos Matias, Bruna Barbosa de Sousa, Déborah Fernanda da Cunha Pereira, Edigar Henrique Vaz Dias, Carla Cristine Neves Mamede, Mayara Ribeiro de Queiroz, Anielle Christine Almeida Silva, Noelio Oliveira Dantas, Andreimar Martins Soares, Júnia de Oliveira Costa, et al.

    Snake venoms are a complex mixture of proteins, organic and inorganic compounds. Some of these proteins, enzymatic or non-enzymatic ones, are able to interact with platelet receptors, causing hemostatic disorders. The possible therapeutic potential of toxins with antiplatelet properties may arouse interest in the pharmacological areas. The present study aimed to purify and characterize an antiplatelet DC protein from Bothrops alternatus snake venom. The protein, called BaltDC (DC protein from B. alternatus snake venom), was purified by a combination of ion-exchange chromatography on DEAE-Sephacel column and gel filtration on Sephadex G-75. The molecular mass was estimated by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (SDS-PAGE). The amino acid sequence of the N-terminal region was carried out by Edman degradation method. Platelet aggregation assays were performed in human platelet-rich plasma (PRP). Infrared (IR) spectroscopy was used in order to elucidate the interactions between BaltDC and platelet membrane. BaltDC ran as a single protein band on SDS-PAGE and showed apparent molecular mass of 32 kDa under reducing or non-reducing conditions. The N-terminal region of the purified protein revealed the amino acid sequence IISPPVCGNELLEVGEECDCGTPENCQNECCDA, which showed identity with other snake venom metalloproteinases (SVMPs). BaltDC was devoid of proteolytic, hemorrhagic, defibrinating or coagulant activities, but it showed a specific inhibitory effect on platelet aggregation induced by ristocetin and epinephrine in PRP. IR analysis spectra strongly suggests that PO3 2− groups, present in BaltDC, form hydrogen bonds with the PO2 − groups present in the non-lipid portion of the membrane platelets. BaltDC may be of medical interest since it was able to inhibit platelet aggregation.


  • The role of platelets in hemostasis and the effects of snake venom toxins on platelet function

    by Mayara Ribeiro de Queiroz, Bruna Barbosa de Sousa, Déborah Fernanda da Cunha Pereira, Carla Cristine Neves Mamede, Mariana Santos Matias, Nadia Cristina Gomes de Morais, Júnia de Oliveira Costa, Fábio de Oliveira


  • Structural and functional comparison of proteolytic enzymes from plant latex and snake venoms

    by Júnia de O. Costa, Kelly C. Fonseca, Mário S. Garrote-Filho, Cleine C. Cunha, Mariana V. de Freitas, Heliane S. Silva, Renata B. Araújo, Nilson Penha-Silva, Fábio de Oliveira


  • Bhalternin: Functional and structural characterization of a new thrombin-like enzyme from Bothrops alternatus snake venom

    by Júnia de O. Costa, Kelly C. Fonseca, Carla C. Neves Mamede, Marcelo E. Beletti, Norival A. Santos-Filho, Andreimar M. Soares, Eliane C. Arantes, Silvia N.S. Hirayama, Heloísa S. Selistre-De-Araújo, Fernando Fonseca, et al.


  • Purification and biochemical characterization of Eumiliin from Euphorbia milii var. hislopii latex

    by K.C. Fonseca, N.C.G. Morais, M.R. Queiroz, M.C. Silva, M.S. Gomes, J.O. Costa, C.C.N. Mamede, F.S. Torres, N. Penha-Silva, M.E. Beletti, et al.


  • Isolation and structural characterization of a new fibrin(ogen)olytic metalloproteinase from Bothrops moojeni snake venom

    by Carolina P. Bernardes, Norival A. Santos-Filho, Tássia R. Costa, Mário S.R. Gomes, Fernanda S. Torres, Júnia Costa, Márcia H. Borges, Michael Richardson, Daniel M. dos Santos, Adriano M. de Castro Pimenta, et al.